Chung Mina K, Patton Kristen K, Lau Chu-Pak, Dal Forno Alexander R J, Al-Khatib Sana M, Arora Vanita, Birgersdotter-Green Ulrika Maria, Cha Yong-Mei, Chung Eugene H, Cronin Edmond M, Curtis Anne B, Cygankiewicz Iwona, Dandamudi Gopi, Dubin Anne M, Ensch Douglas P, Glotzer Taya V, Gold Michael R, Goldberger Zachary D, Gopinathannair Rakesh, Gorodeski Eiran Z, Gutierrez Alejandra, Guzman Juan C, Huang Weijian, Imrey Peter B, Indik Julia H, Karim Saima, Karpawich Peter P, Khaykin Yaariv, Kiehl Erich L, Kron Jordana, Kutyifa Valentina, Link Mark S, Marine Joseph E, Mullens Wilfried, Park Seung-Jung, Parkash Ratika, Patete Manuel F, Pathak Rajeev Kumar, Perona Carlos A, Rickard John, Schoenfeld Mark H, Seow Swee-Chong, Shen Win-Kuang, Shoda Morio, Singh Jagmeet P, Slotwiner David J, Sridhar Arun Raghav M, Srivatsa Uma N, Stecker Eric C, Tanawuttiwat Tanyanan, Tang W H Wilson, Tapias Carlos Andres, Tracy Cynthia M, Upadhyay Gaurav A, Varma Niraj, Vernooy Kevin, Vijayaraman Pugazhendhi, Worsnick Sarah Ann, Zareba Wojciech, Zeitler Emily P, Lopez-Cabanillas Nestor, Ellenbogen Kenneth A, Hua Wei, Ikeda Takanori, Mackall Judith A, Mason Pamela K, McLeod Christopher J, Mela Theofanie, Moore Jeremy P, Racenet Laurel Kay
Cleveland Clinic Cleveland Ohio USA.
University of Washington Seattle Washington USA.
J Arrhythm. 2023 Aug 2;39(5):681-756. doi: 10.1002/joa3.12872. eCollection 2023 Oct.
Cardiac physiologic pacing (CPP), encompassing cardiac resynchronization therapy (CRT) and conduction system pacing (CSP), has emerged as a pacing therapy strategy that may mitigate or prevent the development of heart failure (HF) in patients with ventricular dyssynchrony or pacing-induced cardiomyopathy. This clinical practice guideline is intended to provide guidance on indications for CRT for HF therapy and CPP in patients with pacemaker indications or HF, patient selection, pre-procedure evaluation and preparation, implant procedure management, follow-up evaluation and optimization of CPP response, and use in pediatric populations. Gaps in knowledge, pointing to new directions for future research, are also identified.
心脏生理性起搏(CPP),包括心脏再同步治疗(CRT)和传导系统起搏(CSP),已成为一种起搏治疗策略,可减轻或预防心室不同步或起搏诱导性心肌病患者心力衰竭(HF)的发生。本临床实践指南旨在为有起搏器指征或HF的患者提供关于HF治疗的CRT和CPP的适应证、患者选择、术前评估和准备、植入手术管理、随访评估和CPP反应优化以及在儿科人群中的应用的指导。还确定了知识空白,为未来研究指明了新方向。